Pharma Assay Development

Why Should Pharma Companies Use Pharma Assay Development (PAD) Services?

Rare cell detection, tracking clonal heterogeneity, and determining zygosity and co-occurence of edits at the single-cell level are all critical to the development and commercialization of personalized therapeutics. Partnering with PAD is the only solution to accessing these multi-parametric datasets on a single platform. Biopharmaceutical companies, both large and small, have leveraged PAD to advance their biomarker development, and cell and gene therapy pipelines.

Proof-of-concept study

Validate orthogonal data sets

Targeted and custom assay design

Assay transfer to site/CRO/CDMO

Streamline drug product release

Comprehensive Support Across  the Pharma Workflow

Scope Project

Panel &
Assay Design

Wet Lab

Data Analysis

Long-term
Pipeline
Support

Panel &
Assay Design

8M

Cells analyzed on Tapestri in-house

15+

Novel custom assays developed and transfered to GMP

100+

Publications world-wide from leading KOLs

45+

PAD and IND-enabling projects with Top Global Pharma partners

Explore PAD Services by Application

Cell and Gene  Therapy

Validate gene editing platform for on- and off-target editing
Streamline vector copy number and transduction efficiency assays for drug lot release
Identify the right critical quality attributes (CQAs) to accelerate your path to clinic

Drug and Biomarker Development

Recapitulate and validate disease in humanized models
Uncover molecular resistance mechanisms to improve patient stratification
Reveal complex clonal architectures of co-occurring mutations
Understand clonal phylogeny and selection for lineage tracing and response to drug treatment
Integrate single-cell genotypic and immunophenotypic information to predict relapse on remission samples.

Custom Solutions

If you don’t see an application that fits your needs, ask us about developing a custom solution. To date, we have produced 15 fit-for-purpose assays, with more on the way.

INQUIRE